A number of recent hearings in the House of Representatives have focused on health policy issues, including:

• An Oversight and Government Reform Federal Workforce Subcommittee hearing on H.R. 4489, the “Federal Employees Health Benefits Program Prescription Drug Integrity, Transparency, and Cost Savings Act.”
• A Science and Technology Committee hearing on “How Can NIST (National Institute of Standards and Technology) Better Serve the Needs of the Biomedical Research Community in the 21st Century?”
• An Energy and Commerce Oversight and Investigations Subcommittee hearing entitled “Anthem Blue Cross Premium Hike.”

In addition, today the House Energy and Commerce Health Subcommittee is holding a hearing on medical radiation, and on March 3, the Senate Homeland Security and Governmental Affairs Committee, Federal Financial Management Subcommittee will review oversight challenges in the Medicare Part D prescription drug program.   Two health care fraud hearings have been scheduled for Thursday, March 4. The House Judiciary Subcommittee on Crime, Terrorism and Homeland Security has scheduled a hearing entitled “The Enforcement of the Criminal Laws Against Medicare and Medicaid Fraud,”  and the House Appropriations Labor-HHS Committee is holding a hearing on “Combating Health Care Fraud and Abuse.”